Ben-Avraham D, Karasik D, Verghese J, et al. The complex genetics of gait speed: genome-wide meta-analysis approach. Aging (Albany NY). 2017;9(1):209-246. doi:10.18632/aging.101151
Publications
Lipson M, Reich D. A working model of the deep relationships of diverse modern human genetic lineages outside of Africa. Mol Biol Evol. 2017. doi:10.1093/molbev/msw293
Chang H, Hoshina N, Zhang C, et al. The protocadherin 17 gene affects cognition, personality, amygdala structure and function, synapse development and risk of major mood disorders. Mol Psychiatry. 2017. doi:10.1038/mp.2016.231
Naba A, Clauser KR, Mani DR, Carr SA, Hynes RO. Quantitative proteomic profiling of the extracellular matrix of pancreatic islets during the angiogenic switch and insulinoma progression. Sci Rep. 2017;7:40495. doi:10.1038/srep40495
Muranen T, Iwanicki MP, Curry NL, et al. Starved epithelial cells uptake extracellular matrix for survival. Nat Commun. 2017;8:13989. doi:10.1038/ncomms13989
Charney AW, Ruderfer DM, Stahl EA, et al. Evidence for genetic heterogeneity between clinical subtypes of bipolar disorder. Transl Psychiatry. 2017;7(1):e993. doi:10.1038/tp.2016.242
Tsvetkov P, Sokol E, Jin D, et al. Suppression of 19S proteasome subunits marks emergence of an altered cell state in diverse cancers. Proc Natl Acad Sci U S A. 2017;114(2):382-387. doi:10.1073/pnas.1619067114
Barnes KG, Irving H, Chiumia M, et al. Restriction to gene flow is associated with changes in the molecular basis of pyrethroid resistance in the malaria vector Anopheles funestus. Proc Natl Acad Sci U S A. 2017;114(2):286-291. doi:10.1073/pnas.1615458114
Vasta JD, Choudhary A, Jensen KH, McGrath NA, Raines RT. Prolyl 4-Hydroxylase: Substrate Isosteres in Which an (E)- or (Z)-Alkene Replaces the Prolyl Peptide Bond. Biochemistry. 2017;56(1):219-227. doi:10.1021/acs.biochem.6b00976
Patrick E, Schramm SJ, Ormerod JT, et al. A multi-step classifier addressing cohort heterogeneity improves performance of prognostic biomarkers in three cancer types. Oncotarget. 2017;8(2):2807-2815. doi:10.18632/oncotarget.13203